LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Arsenic Trioxide Injection in a 10 mg per 10 mL vial presentation. The product is ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN DIEGO -- An ...
The use of arsenic trioxide instead of idarubicin in combination with all-trans retinoic acid (ATRA) is a feasible option in patients with acute promyelocytic leukaemia, regardless of risk level, ...
CHICAGO (Reuters Health) - In adults with newly diagnosed acute promyelocytic leukemia (APL), the addition of arsenic trioxide to standard therapy significantly improves survival, according to a phase ...
MDS patients diagnosed according to standard French-American-British criteria received a loading dose of 0.3 mg/kg per day of arsenic trioxide for 5 days followed by a maintenance dose of 0.25 mg/kg ...
CD26 expression in donor stem cell harvest and its correlation with engraftment in human haematopoietic stem cell transplantation: Potential predictor of early engraftment. Use of deep whole ...
From a study that analyzed the therapeutic dilemma of treating acute leukemia (AL) during pregnancy and the delicate balance of improving maternal and fetal outcomes, investigators determined that ...
Researchers at Zhejiang University School of Medicine have identified a single point mutation in the normal PML gene that can block the effect of arsenic trioxide, a frontline drug for acute ...
Combining all-trans retinoic acid (ATRA) with arsenic trioxide (ATO) and idarubicin significantly improved event-free survival (EFS) compared with the standard treatment of ATRA and ...
STRASBOURG, France--(BUSINESS WIRE)--Medsenic, a clinical-stage biopharmaceutical company specializing in the discovery and development of new indications and formulations of arsenic salts for the ...
Trial of Arsenic Trioxide Finds the Drug is Safe and Effective as a Short-Course Treatment for Lupus
Newly published data from a phase IIa drug trial shows the treatment arsenic trioxide (ATO) showed positive results for people with lupus. Initial findings also show encouraging efficacy results for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results